Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tfap2a
|
ENSMUSG00000021359.9 | transcription factor AP-2, alpha |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_40733694_40733845 | Tfap2a | 9 | 0.955465 | 0.79 | 8.6e-13 | Click! |
chr13_40730667_40730845 | Tfap2a | 313 | 0.801234 | 0.78 | 2.3e-12 | Click! |
chr13_40733901_40734210 | Tfap2a | 80 | 0.943541 | 0.75 | 3.0e-11 | Click! |
chr13_40730920_40731111 | Tfap2a | 572 | 0.595029 | 0.74 | 1.2e-10 | Click! |
chr13_40731141_40731501 | Tfap2a | 286 | 0.824795 | 0.64 | 1.2e-07 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_20616739_20617639 | 117.18 |
Gm16090 |
predicted gene 16090 |
48071 |
0.1 |
chr18_20621651_20622570 | 100.83 |
Gm16090 |
predicted gene 16090 |
43150 |
0.11 |
chr18_20625060_20625736 | 53.97 |
Gm16090 |
predicted gene 16090 |
39862 |
0.12 |
chr2_165511107_165511805 | 43.09 |
Slc2a10 |
solute carrier family 2 (facilitated glucose transporter), member 10 |
2675 |
0.23 |
chr18_20625915_20626381 | 29.70 |
Gm16090 |
predicted gene 16090 |
39112 |
0.12 |
chr18_20615543_20616002 | 28.40 |
Gm16090 |
predicted gene 16090 |
49488 |
0.1 |
chr14_14983885_14984321 | 23.73 |
Nek10 |
NIMA (never in mitosis gene a)- related kinase 10 |
53528 |
0.11 |
chr12_3236518_3237725 | 14.31 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr18_3117365_3118622 | 13.71 |
Vmn1r238 |
vomeronasal 1 receptor, 238 |
5419 |
0.17 |
chr15_39197089_39197893 | 13.65 |
Rims2 |
regulating synaptic membrane exocytosis 2 |
770 |
0.61 |
chr2_33130296_33131698 | 13.56 |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
389 |
0.84 |
chr8_4192812_4193553 | 12.29 |
Evi5l |
ecotropic viral integration site 5 like |
1890 |
0.19 |
chr18_20626425_20626742 | 12.20 |
Gm16090 |
predicted gene 16090 |
38677 |
0.12 |
chr18_20627927_20628180 | 11.36 |
Gm16090 |
predicted gene 16090 |
37207 |
0.12 |
chr16_42575508_42575977 | 11.19 |
Gm49739 |
predicted gene, 49739 |
88184 |
0.1 |
chr19_10041145_10042475 | 10.75 |
Fads3 |
fatty acid desaturase 3 |
78 |
0.96 |
chr14_39473001_39473750 | 9.78 |
Nrg3 |
neuregulin 3 |
287 |
0.95 |
chr4_109977849_109978740 | 9.72 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
241 |
0.73 |
chr18_38212155_38213063 | 9.50 |
Pcdh1 |
protocadherin 1 |
556 |
0.57 |
chr5_32713265_32714499 | 9.46 |
Gm43852 |
predicted gene 43852 |
106 |
0.94 |
chr18_20624320_20624587 | 9.31 |
Gm16090 |
predicted gene 16090 |
40807 |
0.12 |
chr8_84945228_84946066 | 9.11 |
Rtbdn |
retbindin |
1344 |
0.18 |
chr13_54948652_54949299 | 8.93 |
Unc5a |
unc-5 netrin receptor A |
436 |
0.79 |
chr13_24279825_24280171 | 8.76 |
Carmil1 |
capping protein regulator and myosin 1 linker 1 |
488 |
0.73 |
chr10_5922652_5922867 | 8.74 |
Rgs17 |
regulator of G-protein signaling 17 |
359 |
0.92 |
chr9_83806172_83806700 | 8.73 |
Elovl4 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
159 |
0.96 |
chr7_79515104_79515926 | 8.26 |
Mir9-3hg |
Mir9-3 host gene |
80 |
0.92 |
chr7_34570196_34571084 | 8.18 |
Gm12784 |
predicted gene 12784 |
23434 |
0.15 |
chr11_6599159_6600158 | 8.09 |
Nacad |
NAC alpha domain containing |
266 |
0.81 |
chr1_38835547_38836894 | 7.94 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
154 |
0.95 |
chr6_6878531_6879191 | 7.88 |
Dlx5 |
distal-less homeobox 5 |
3207 |
0.16 |
chr13_15759168_15760299 | 7.84 |
Gm48408 |
predicted gene, 48408 |
10387 |
0.18 |
chr12_29871996_29872873 | 7.83 |
Myt1l |
myelin transcription factor 1-like |
20886 |
0.24 |
chr7_113765650_113766794 | 7.78 |
Spon1 |
spondin 1, (f-spondin) extracellular matrix protein |
48 |
0.98 |
chr18_20618481_20618693 | 7.61 |
Gm16090 |
predicted gene 16090 |
46673 |
0.11 |
chr4_46991653_46992403 | 7.58 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
155 |
0.95 |
chr18_20627203_20627433 | 7.56 |
Gm16090 |
predicted gene 16090 |
37942 |
0.12 |
chr2_77816275_77817277 | 7.53 |
Zfp385b |
zinc finger protein 385B |
40 |
0.98 |
chr4_148287581_148287935 | 7.47 |
Disp3 |
dispatched RND transporter family member 3 |
207 |
0.93 |
chr10_58227289_58228680 | 7.43 |
Gm10807 |
predicted gene 10807 |
667 |
0.56 |
chr3_83789572_83790373 | 7.35 |
Gm26771 |
predicted gene, 26771 |
16 |
0.97 |
chr9_62536098_62537614 | 7.25 |
Coro2b |
coronin, actin binding protein, 2B |
104 |
0.97 |
chr7_109010582_109011352 | 7.24 |
Tub |
tubby bipartite transcription factor |
142 |
0.95 |
chr1_31233663_31234000 | 7.17 |
Pih1d3 |
PIH1 domain containing 3 |
10993 |
0.12 |
chr10_32889642_32890523 | 7.07 |
Nkain2 |
Na+/K+ transporting ATPase interacting 2 |
234 |
0.95 |
chr17_52601056_52601789 | 6.88 |
Gm27217 |
predicted gene 27217 |
1238 |
0.39 |
chr15_12365691_12366546 | 6.85 |
1810049J17Rik |
RIKEN cDNA 1810049J17 gene |
44219 |
0.12 |
chr10_78464271_78465733 | 6.73 |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
27 |
0.93 |
chr4_148239816_148239967 | 6.64 |
Disp3 |
dispatched RND transporter family member 3 |
20860 |
0.14 |
chr14_3948585_3949537 | 6.64 |
Gm3095 |
predicted gene 3095 |
14486 |
0.11 |
chr1_66386801_66386993 | 6.61 |
Map2 |
microtubule-associated protein 2 |
48 |
0.98 |
chr5_29735522_29736024 | 6.60 |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
85 |
0.61 |
chr11_3132475_3133419 | 6.59 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
3060 |
0.17 |
chr7_79535266_79535447 | 6.54 |
Gm35040 |
predicted gene, 35040 |
687 |
0.49 |
chr18_20621175_20621448 | 6.47 |
Gm16090 |
predicted gene 16090 |
43949 |
0.11 |
chr18_20628403_20628558 | 6.47 |
Gm16090 |
predicted gene 16090 |
36780 |
0.13 |
chr2_151701768_151703133 | 6.45 |
Tmem74b |
transmembrane protein 74B |
139 |
0.92 |
chr3_118434274_118434540 | 6.44 |
Gm24155 |
predicted gene, 24155 |
314 |
0.35 |
chr9_124439906_124440949 | 6.35 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr18_20628591_20628850 | 6.33 |
Gm16090 |
predicted gene 16090 |
36540 |
0.13 |
chr19_33589843_33590299 | 6.29 |
AC141640.1 |
renalase, FAD-dependent amine oxidase (Rnls) pseudogene |
64 |
0.72 |
chr7_79504714_79505014 | 6.28 |
Mir9-3 |
microRNA 9-3 |
400 |
0.7 |
chr2_21010740_21011090 | 6.27 |
Gm13375 |
predicted gene 13375 |
41861 |
0.14 |
chr4_142274436_142274807 | 6.25 |
Kazn |
kazrin, periplakin interacting protein |
35220 |
0.18 |
chr13_88821410_88822253 | 6.22 |
Edil3 |
EGF-like repeats and discoidin I-like domains 3 |
189 |
0.97 |
chr8_127552128_127552360 | 6.21 |
Gm6921 |
predicted pseudogene 6921 |
9191 |
0.23 |
chr19_33761590_33762005 | 6.19 |
Lipo3 |
lipase, member O3 |
154 |
0.94 |
chr11_32157683_32158170 | 6.19 |
Gm12109 |
predicted gene 12109 |
27079 |
0.12 |
chr9_14751478_14752576 | 6.17 |
Fut4 |
fucosyltransferase 4 |
366 |
0.74 |
chr1_18058368_18058994 | 6.08 |
Gm28756 |
predicted gene 28756 |
109 |
0.82 |
chr14_5000842_5001422 | 6.04 |
Gm3298 |
predicted gene 3298 |
14759 |
0.13 |
chr19_47493170_47493582 | 6.03 |
Stn1 |
STN1, CST complex subunit |
15397 |
0.15 |
chr14_4649279_4649596 | 6.01 |
Gm3239 |
predicted gene 3239 |
14755 |
0.11 |
chrX_170675440_170675591 | 6.01 |
Asmt |
acetylserotonin O-methyltransferase |
2871 |
0.39 |
chr2_4437003_4437281 | 5.98 |
Gm13175 |
predicted gene 13175 |
29528 |
0.16 |
chr2_54435866_54436297 | 5.95 |
Galnt13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
236 |
0.96 |
chr12_3364588_3366025 | 5.94 |
Kif3c |
kinesin family member 3C |
116 |
0.94 |
chr13_99513103_99513583 | 5.93 |
Map1b |
microtubule-associated protein 1B |
3175 |
0.2 |
chr2_181134637_181135435 | 5.91 |
Kcnq2 |
potassium voltage-gated channel, subfamily Q, member 2 |
91 |
0.95 |
chr9_26733143_26733768 | 5.90 |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
273 |
0.88 |
chr14_7488846_7489218 | 5.89 |
Gm3752 |
predicted gene 3752 |
5270 |
0.15 |
chr7_79148252_79148910 | 5.86 |
Mfge8 |
milk fat globule-EGF factor 8 protein |
350 |
0.87 |
chr7_79497714_79498195 | 5.85 |
Mir9-3hg |
Mir9-3 host gene |
2072 |
0.16 |
chr1_120115426_120115881 | 5.85 |
Dbi |
diazepam binding inhibitor |
4485 |
0.2 |
chr15_25413961_25414576 | 5.80 |
Gm5468 |
predicted gene 5468 |
76 |
0.84 |
chr14_100619435_100619663 | 5.80 |
Gm49238 |
predicted gene, 49238 |
36212 |
0.16 |
chr1_79858099_79859256 | 5.79 |
Serpine2 |
serine (or cysteine) peptidase inhibitor, clade E, member 2 |
19 |
0.98 |
chr16_28752897_28753619 | 5.78 |
Fgf12 |
fibroblast growth factor 12 |
190 |
0.97 |
chr14_4854937_4855331 | 5.78 |
Gm3264 |
predicted gene 3264 |
442 |
0.76 |
chr9_8900765_8902148 | 5.78 |
Pgr |
progesterone receptor |
988 |
0.68 |
chr6_16317881_16318284 | 5.75 |
Gm3148 |
predicted gene 3148 |
80455 |
0.1 |
chr10_58812655_58813414 | 5.74 |
Gm9987 |
predicted gene 9987 |
108 |
0.77 |
chr13_13783865_13785053 | 5.74 |
Gng4 |
guanine nucleotide binding protein (G protein), gamma 4 |
130 |
0.96 |
chr17_68841706_68842242 | 5.72 |
Gm49949 |
predicted gene, 49949 |
2051 |
0.29 |
chr12_27064915_27065316 | 5.71 |
Gm9866 |
predicted gene 9866 |
49880 |
0.18 |
chr16_44687184_44688343 | 5.71 |
Nepro |
nucleolus and neural progenitor protein |
36538 |
0.14 |
chr2_102451171_102452295 | 5.71 |
Fjx1 |
four jointed box 1 |
766 |
0.72 |
chr15_85708879_85709635 | 5.70 |
Mirlet7b |
microRNA let7b |
1938 |
0.23 |
chr14_79203841_79204062 | 5.69 |
Gm4632 |
predicted gene 4632 |
4761 |
0.18 |
chr17_13759899_13761731 | 5.66 |
Afdn |
afadin, adherens junction formation factor |
141 |
0.73 |
chr15_12739831_12740185 | 5.65 |
Pdzd2 |
PDZ domain containing 2 |
84 |
0.96 |
chr3_117359660_117360545 | 5.63 |
Plppr4 |
phospholipid phosphatase related 4 |
146 |
0.97 |
chr2_4042199_4042395 | 5.62 |
Gm2639 |
predicted gene 2639 |
10262 |
0.15 |
chr5_14514560_14515558 | 5.55 |
Pclo |
piccolo (presynaptic cytomatrix protein) |
66 |
0.97 |
chr2_53437450_53438022 | 5.51 |
Gm13501 |
predicted gene 13501 |
39249 |
0.2 |
chr18_52768463_52769042 | 5.51 |
Sncaip |
synuclein, alpha interacting protein (synphilin) |
20 |
0.98 |
chr18_20626992_20627160 | 5.50 |
Gm16090 |
predicted gene 16090 |
38184 |
0.12 |
chr7_111028865_111029648 | 5.48 |
Ctr9 |
CTR9 homolog, Paf1/RNA polymerase II complex component |
243 |
0.92 |
chr5_112213440_112213673 | 5.48 |
Gm26953 |
predicted gene, 26953 |
1905 |
0.23 |
chr3_8510910_8511440 | 5.47 |
Stmn2 |
stathmin-like 2 |
1589 |
0.43 |
chr14_5501056_5501435 | 5.44 |
Gm3488 |
predicted gene, 3488 |
429 |
0.73 |
chr6_90495493_90495923 | 5.42 |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
9281 |
0.11 |
chr9_41918970_41919408 | 5.42 |
Gm40513 |
predicted gene, 40513 |
28585 |
0.14 |
chr5_36869921_36870140 | 5.41 |
Ppp2r2c |
protein phosphatase 2, regulatory subunit B, gamma |
1367 |
0.36 |
chr2_178175383_178175588 | 5.41 |
Phactr3 |
phosphatase and actin regulator 3 |
136 |
0.97 |
chrX_13346707_13347908 | 5.40 |
Gm7129 |
predicted gene 7129 |
20288 |
0.14 |
chr10_81364518_81366962 | 5.40 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr7_76186010_76186195 | 5.40 |
Agbl1 |
ATP/GTP binding protein-like 1 |
43785 |
0.17 |
chr7_18926314_18927174 | 5.39 |
Nova2 |
NOVA alternative splicing regulator 2 |
856 |
0.42 |
chr18_3116148_3116568 | 5.37 |
Vmn1r238 |
vomeronasal 1 receptor, 238 |
7054 |
0.16 |
chr8_81015061_81015486 | 5.37 |
Gm9725 |
predicted gene 9725 |
130 |
0.76 |
chr5_71976591_71976789 | 5.36 |
Gm15617 |
predicted gene 15617 |
56798 |
0.14 |
chr6_30552193_30552508 | 5.35 |
Cpa2 |
carboxypeptidase A2, pancreatic |
447 |
0.74 |
chr14_25611721_25612317 | 5.35 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
4181 |
0.23 |
chr6_55451539_55452374 | 5.34 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
22 |
0.98 |
chr18_89768868_89769818 | 5.33 |
Dok6 |
docking protein 6 |
185 |
0.96 |
chr6_127701185_127701975 | 5.33 |
Gm43634 |
predicted gene 43634 |
57140 |
0.08 |
chr17_9580072_9580515 | 5.31 |
Gm49807 |
predicted gene, 49807 |
30602 |
0.2 |
chr7_19094759_19096427 | 5.29 |
Six5 |
sine oculis-related homeobox 5 |
999 |
0.28 |
chr14_7244047_7245236 | 5.27 |
Gm5456 |
predicted gene 5456 |
3199 |
0.18 |
chr6_85320380_85320887 | 5.26 |
Sfxn5 |
sideroflexin 5 |
235 |
0.91 |
chr14_6427330_6427709 | 5.24 |
Lamtor3-ps |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3, pseudogene |
15037 |
0.14 |
chr2_143545715_143546271 | 5.22 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
16 |
0.67 |
chr11_32220828_32222435 | 5.21 |
Rhbdf1 |
rhomboid 5 homolog 1 |
613 |
0.58 |
chr18_20626775_20626931 | 5.18 |
Gm16090 |
predicted gene 16090 |
38407 |
0.12 |
chr10_75559168_75559843 | 5.16 |
Lrrc75b |
leucine rich repeat containing 75B |
825 |
0.43 |
chr10_70484969_70485278 | 5.14 |
Gm29783 |
predicted gene, 29783 |
20125 |
0.19 |
chr2_101592687_101592869 | 5.11 |
B230118H07Rik |
RIKEN cDNA B230118H07 gene |
7844 |
0.19 |
chr1_82634564_82634787 | 5.09 |
n-R5s213 |
nuclear encoded rRNA 5S 213 |
338 |
0.87 |
chr12_80759665_80760570 | 5.08 |
Ccdc177 |
coiled-coil domain containing 177 |
570 |
0.61 |
chr1_17145272_17145872 | 5.07 |
Gdap1 |
ganglioside-induced differentiation-associated-protein 1 |
104 |
0.97 |
chr1_175492264_175493051 | 5.07 |
Rgs7 |
regulator of G protein signaling 7 |
157 |
0.97 |
chr8_23562129_23562317 | 5.06 |
Zmat4 |
zinc finger, matrin type 4 |
73796 |
0.11 |
chr9_21168186_21168813 | 5.05 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
2785 |
0.14 |
chr10_52940614_52940777 | 5.04 |
Gm25664 |
predicted gene, 25664 |
35057 |
0.19 |
chr8_9771269_9772260 | 5.04 |
Fam155a |
family with sequence similarity 155, member A |
603 |
0.53 |
chr6_77979020_77979189 | 5.02 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
446 |
0.85 |
chr3_103575082_103575659 | 5.01 |
Syt6 |
synaptotagmin VI |
8 |
0.98 |
chr17_25570380_25571317 | 5.00 |
Cerox1 |
cytoplasmic endogenous regulator of oxidative phosphorylation 1 |
4 |
0.66 |
chr8_9772530_9772715 | 4.99 |
Fam155a |
family with sequence similarity 155, member A |
1461 |
0.3 |
chr9_91387498_91387693 | 4.97 |
Zic4 |
zinc finger protein of the cerebellum 4 |
5185 |
0.13 |
chr19_36534720_36535517 | 4.97 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
19521 |
0.2 |
chr7_129664007_129664606 | 4.97 |
Gm33248 |
predicted gene, 33248 |
3099 |
0.26 |
chr15_97992440_97993334 | 4.96 |
Col2a1 |
collagen, type II, alpha 1 |
2411 |
0.25 |
chr14_7027899_7028078 | 4.95 |
Gm10406 |
predicted gene 10406 |
539 |
0.7 |
chr12_86989961_86990586 | 4.95 |
Zdhhc22 |
zinc finger, DHHC-type containing 22 |
157 |
0.94 |
chr2_3117961_3119194 | 4.95 |
Fam171a1 |
family with sequence similarity 171, member A1 |
108 |
0.97 |
chr2_115852535_115853157 | 4.93 |
Meis2 |
Meis homeobox 2 |
16021 |
0.28 |
chr8_107986841_107986992 | 4.92 |
Zfhx3 |
zinc finger homeobox 3 |
7639 |
0.29 |
chr14_34819764_34820558 | 4.90 |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
53 |
0.98 |
chr18_77564045_77564233 | 4.90 |
Rnf165 |
ring finger protein 165 |
470 |
0.85 |
chr4_49058861_49059294 | 4.89 |
Plppr1 |
phospholipid phosphatase related 1 |
196 |
0.96 |
chr19_9898848_9899750 | 4.88 |
Incenp |
inner centromere protein |
82 |
0.76 |
chr9_61293742_61293899 | 4.86 |
B930092H01Rik |
RIKEN cDNA B930092H01 gene |
11 |
0.98 |
chr9_13425136_13425317 | 4.86 |
Phxr4 |
per-hexamer repeat gene 4 |
6135 |
0.22 |
chr9_30943057_30943301 | 4.85 |
Adamts8 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 8 |
279 |
0.92 |
chr17_68837314_68837806 | 4.84 |
Gm38593 |
predicted gene, 38593 |
334 |
0.56 |
chr6_29023980_29024534 | 4.84 |
Mir129-1 |
microRNA 129-1 |
1638 |
0.36 |
chr9_45663652_45664379 | 4.82 |
Dscaml1 |
DS cell adhesion molecule like 1 |
8822 |
0.19 |
chr14_7174792_7175177 | 4.82 |
Gm3512 |
predicted gene 3512 |
451 |
0.77 |
chr16_74397266_74397471 | 4.81 |
Robo2 |
roundabout guidance receptor 2 |
13544 |
0.25 |
chr14_3331997_3332403 | 4.80 |
Gm2956 |
predicted gene 2956 |
427 |
0.78 |
chr5_17499846_17500052 | 4.79 |
Gm7047 |
predicted gene 7047 |
6726 |
0.23 |
chr3_17786744_17787083 | 4.79 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
3008 |
0.25 |
chr12_105336634_105337535 | 4.78 |
Tunar |
Tcl1 upstream neural differentiation associated RNA |
91 |
0.97 |
chr13_109053247_109053648 | 4.78 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
62789 |
0.16 |
chr2_127521161_127522051 | 4.77 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr7_44442436_44442849 | 4.76 |
Lrrc4b |
leucine rich repeat containing 4B |
95 |
0.92 |
chr10_69466336_69466487 | 4.76 |
Gm18636 |
predicted gene, 18636 |
42663 |
0.15 |
chr6_42323997_42324544 | 4.76 |
Fam131b |
family with sequence similarity 131, member B |
322 |
0.78 |
chr7_139834023_139834682 | 4.75 |
Adgra1 |
adhesion G protein-coupled receptor A1 |
13 |
0.97 |
chr14_5460616_5460971 | 4.75 |
Gm3194 |
predicted gene 3194 |
5326 |
0.13 |
chr13_12105853_12107098 | 4.75 |
Ryr2 |
ryanodine receptor 2, cardiac |
16 |
0.98 |
chr2_136712228_136712733 | 4.74 |
Snap25 |
synaptosomal-associated protein 25 |
973 |
0.59 |
chr3_108085301_108086522 | 4.73 |
Gm12500 |
predicted gene 12500 |
65 |
0.8 |
chr6_47366314_47366501 | 4.72 |
Gm18584 |
predicted gene, 18584 |
66682 |
0.11 |
chr5_116591724_116592384 | 4.72 |
Srrm4 |
serine/arginine repetitive matrix 4 |
237 |
0.93 |
chr12_112747298_112747750 | 4.71 |
Cep170b |
centrosomal protein 170B |
3560 |
0.12 |
chr14_6605363_6605553 | 4.70 |
Gm3629 |
predicted gene 3629 |
14845 |
0.15 |
chrX_105121571_105121737 | 4.70 |
Magee1 |
melanoma antigen, family E, 1 |
1276 |
0.4 |
chr18_45896851_45897467 | 4.69 |
A330093E20Rik |
RIKEN cDNA A330093E20 gene |
650 |
0.79 |
chr2_26594675_26595827 | 4.69 |
Egfl7 |
EGF-like domain 7 |
3104 |
0.11 |
chr3_68071449_68071752 | 4.69 |
Schip1 |
schwannomin interacting protein 1 |
6798 |
0.31 |
chr3_38261917_38262082 | 4.69 |
Gm2965 |
predicted gene 2965 |
38548 |
0.15 |
chr14_4018192_4019443 | 4.69 |
Gm5796 |
predicted gene 5796 |
5124 |
0.14 |
chr6_47367638_47368002 | 4.69 |
Gm18584 |
predicted gene, 18584 |
65269 |
0.11 |
chr14_7315485_7315671 | 4.68 |
Gm3739 |
predicted gene 3739 |
529 |
0.71 |
chr4_136835920_136836937 | 4.68 |
Ephb2 |
Eph receptor B2 |
440 |
0.83 |
chr5_33997006_33997498 | 4.67 |
Nat8l |
N-acetyltransferase 8-like |
1268 |
0.3 |
chr15_100909741_100909948 | 4.67 |
Scn8a |
sodium channel, voltage-gated, type VIII, alpha |
23585 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.7 | 45.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
5.5 | 22.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
5.4 | 32.5 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
4.6 | 13.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.9 | 3.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
3.5 | 17.3 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
3.2 | 9.7 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
3.1 | 27.7 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
3.0 | 12.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
2.9 | 8.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
2.7 | 8.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
2.7 | 13.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.6 | 5.2 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
2.5 | 7.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.5 | 9.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.5 | 7.4 | GO:0060166 | olfactory pit development(GO:0060166) |
2.5 | 17.2 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
2.4 | 19.6 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
2.4 | 9.7 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
2.4 | 7.2 | GO:0030242 | pexophagy(GO:0030242) |
2.4 | 7.2 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
2.4 | 7.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
2.4 | 7.1 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.3 | 11.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.3 | 2.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.3 | 4.5 | GO:0048880 | sensory system development(GO:0048880) |
2.2 | 2.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
2.2 | 6.7 | GO:0046959 | habituation(GO:0046959) |
2.2 | 8.8 | GO:0007412 | axon target recognition(GO:0007412) |
2.2 | 17.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.1 | 6.4 | GO:0021564 | vagus nerve development(GO:0021564) |
2.1 | 10.6 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
2.1 | 6.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.1 | 6.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.0 | 4.1 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
2.0 | 6.1 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
2.0 | 36.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.9 | 9.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.9 | 9.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.8 | 5.5 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.8 | 3.6 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
1.8 | 5.3 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
1.7 | 5.2 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.7 | 5.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.7 | 1.7 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.7 | 6.8 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.7 | 15.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.7 | 5.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
1.7 | 5.0 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.7 | 1.7 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.6 | 4.9 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.6 | 6.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.6 | 3.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.6 | 4.8 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.6 | 6.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.5 | 4.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.5 | 4.6 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.5 | 6.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
1.5 | 1.5 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.5 | 4.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.5 | 4.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.5 | 4.5 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
1.5 | 1.5 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.5 | 1.5 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
1.5 | 2.9 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.4 | 1.4 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
1.4 | 2.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.4 | 11.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.4 | 7.2 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.4 | 4.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.4 | 4.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.4 | 4.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.4 | 9.6 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.3 | 4.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.3 | 4.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.3 | 6.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.3 | 3.9 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
1.3 | 7.7 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.3 | 10.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.3 | 5.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.3 | 3.8 | GO:0030070 | insulin processing(GO:0030070) |
1.3 | 2.5 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.3 | 5.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.3 | 3.8 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.3 | 2.5 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.2 | 3.7 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.2 | 27.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.2 | 3.7 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.2 | 2.4 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.2 | 4.8 | GO:0021764 | amygdala development(GO:0021764) |
1.2 | 10.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.2 | 3.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.2 | 3.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.2 | 1.2 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
1.2 | 3.5 | GO:0060618 | nipple development(GO:0060618) |
1.2 | 3.5 | GO:0010996 | response to auditory stimulus(GO:0010996) |
1.2 | 1.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.2 | 3.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.1 | 3.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.1 | 2.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.1 | 3.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.1 | 3.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.1 | 7.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.1 | 15.7 | GO:0001964 | startle response(GO:0001964) |
1.1 | 4.5 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.1 | 5.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.1 | 1.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.1 | 4.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.1 | 3.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.1 | 3.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.1 | 1.1 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
1.0 | 3.1 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
1.0 | 4.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.0 | 9.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
1.0 | 81.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.0 | 2.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
1.0 | 6.8 | GO:0071625 | vocalization behavior(GO:0071625) |
1.0 | 2.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.0 | 1.9 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
1.0 | 3.9 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.0 | 3.9 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.0 | 3.8 | GO:0090427 | activation of meiosis(GO:0090427) |
1.0 | 15.3 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.9 | 45.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.9 | 1.9 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.9 | 13.0 | GO:0060384 | innervation(GO:0060384) |
0.9 | 8.3 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.9 | 3.7 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.9 | 1.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.9 | 1.8 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.9 | 9.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.9 | 19.1 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.9 | 3.6 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.9 | 14.4 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.9 | 7.2 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.9 | 9.9 | GO:0036065 | fucosylation(GO:0036065) |
0.9 | 2.7 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.9 | 3.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.9 | 6.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.9 | 10.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.9 | 0.9 | GO:0090135 | actin filament branching(GO:0090135) |
0.9 | 4.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.9 | 2.6 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.9 | 2.6 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.8 | 3.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.8 | 3.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.8 | 2.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.8 | 2.5 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.8 | 0.8 | GO:1903416 | response to glycoside(GO:1903416) |
0.8 | 7.5 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.8 | 0.8 | GO:0021586 | pons maturation(GO:0021586) |
0.8 | 1.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.8 | 3.3 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.8 | 1.6 | GO:0046958 | nonassociative learning(GO:0046958) |
0.8 | 0.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.8 | 1.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.8 | 6.5 | GO:0022038 | corpus callosum development(GO:0022038) |
0.8 | 1.6 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.8 | 2.4 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.8 | 9.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.8 | 1.6 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.8 | 1.6 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.8 | 7.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.8 | 1.6 | GO:0008355 | olfactory learning(GO:0008355) |
0.8 | 10.9 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.8 | 5.4 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.8 | 3.1 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.8 | 3.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.8 | 3.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.8 | 2.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.7 | 1.5 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.7 | 5.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.7 | 3.7 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.7 | 2.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.7 | 2.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.7 | 9.5 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.7 | 2.2 | GO:0061055 | myotome development(GO:0061055) |
0.7 | 2.9 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.7 | 1.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.7 | 2.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.7 | 12.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.7 | 2.1 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.7 | 7.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.7 | 3.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.7 | 1.4 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.7 | 2.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.7 | 13.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.7 | 2.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.7 | 2.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.7 | 6.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.7 | 0.7 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.7 | 2.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.7 | 0.7 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.7 | 1.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.7 | 0.7 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.6 | 0.6 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.6 | 1.9 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.6 | 1.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 3.8 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.6 | 1.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.6 | 1.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.6 | 1.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.6 | 1.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.6 | 2.5 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.6 | 2.5 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.6 | 1.2 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.6 | 0.6 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.6 | 6.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.6 | 1.8 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.6 | 3.0 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.6 | 0.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.6 | 2.4 | GO:0071321 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.6 | 4.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.6 | 1.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.6 | 0.6 | GO:0030421 | defecation(GO:0030421) |
0.6 | 0.6 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.6 | 1.8 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.6 | 1.8 | GO:0086014 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.6 | 1.8 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.6 | 1.8 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.6 | 2.3 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.6 | 1.1 | GO:0060594 | mammary gland specification(GO:0060594) |
0.6 | 2.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.6 | 7.4 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.6 | 1.7 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.6 | 1.7 | GO:0060914 | heart formation(GO:0060914) |
0.6 | 1.1 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.6 | 7.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.6 | 0.6 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.6 | 2.8 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.5 | 1.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.5 | 1.1 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.5 | 1.6 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.5 | 2.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.5 | 1.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.5 | 4.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.5 | 2.7 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.5 | 2.7 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.5 | 1.1 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.5 | 1.6 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 1.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 1.1 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.5 | 0.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.5 | 1.6 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.5 | 0.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.5 | 2.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.5 | 1.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.5 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.5 | 1.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.5 | 1.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.5 | 0.5 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.5 | 3.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.5 | 3.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.5 | 1.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.5 | 14.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.5 | 1.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.5 | 3.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.5 | 4.9 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.5 | 4.4 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.5 | 1.5 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.5 | 1.5 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.5 | 1.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.5 | 0.5 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.5 | 1.0 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.5 | 1.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.5 | 20.3 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.5 | 1.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.5 | 2.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.5 | 1.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.5 | 4.2 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
0.5 | 0.9 | GO:0048664 | neuron fate determination(GO:0048664) |
0.5 | 1.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.5 | 1.9 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.5 | 2.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.5 | 1.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.5 | 1.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.5 | 9.3 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.5 | 0.5 | GO:0043307 | eosinophil activation(GO:0043307) |
0.5 | 0.9 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.5 | 0.9 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.5 | 1.4 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.5 | 1.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.5 | 0.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.5 | 0.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 0.9 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.5 | 1.4 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) |
0.5 | 2.3 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.4 | 0.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.4 | 0.9 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.4 | 1.8 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.4 | 0.9 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.4 | 2.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.4 | 1.3 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.4 | 6.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 1.3 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.4 | 3.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.4 | 2.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.4 | 1.3 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 2.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 1.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 0.4 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.4 | 0.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.4 | 1.7 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.4 | 1.3 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 1.7 | GO:0042637 | catagen(GO:0042637) |
0.4 | 1.7 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.4 | 3.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 2.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 0.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.4 | 30.2 | GO:0071804 | cellular potassium ion transport(GO:0071804) |
0.4 | 1.3 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.4 | 2.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.4 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 1.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 2.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.4 | 0.8 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 1.2 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.4 | 0.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 1.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.4 | 1.2 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.4 | 4.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.4 | 0.8 | GO:0042161 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.4 | 0.8 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.4 | 1.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.4 | 1.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.4 | 1.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.4 | 0.8 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.4 | 1.6 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.4 | 1.6 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.4 | 2.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.4 | 1.2 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.4 | 1.5 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.4 | 0.8 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.4 | 1.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.4 | 1.9 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.4 | 2.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 1.1 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.4 | 0.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.4 | 0.4 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.4 | 2.2 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.4 | 1.1 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.4 | 0.4 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.4 | 1.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 0.7 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.4 | 1.1 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.4 | 1.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.4 | 1.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.4 | 1.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.4 | 0.7 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.4 | 0.4 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.4 | 2.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.4 | 1.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.4 | 2.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.4 | 0.7 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.4 | 0.7 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.4 | 2.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 1.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.3 | 1.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.3 | 4.5 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.3 | 1.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 0.3 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.3 | 1.0 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.3 | 1.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 0.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 0.7 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.3 | 0.7 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.3 | 2.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 0.3 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.3 | 1.0 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 1.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 1.6 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.3 | 2.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.3 | 1.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 1.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.3 | 1.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 1.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 2.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 0.9 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.3 | 1.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 2.5 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.3 | 2.2 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.3 | 1.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.3 | 1.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 0.6 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.3 | 0.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 0.9 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.3 | 1.5 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.3 | 0.6 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.3 | 0.6 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.3 | 7.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 0.3 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.3 | 0.6 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 | 0.6 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 0.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.3 | 1.4 | GO:0021854 | hypothalamus development(GO:0021854) |
0.3 | 2.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 0.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 1.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.3 | 0.6 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.3 | 0.3 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.3 | 0.8 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.3 | 0.5 | GO:0050651 | dermatan sulfate biosynthetic process(GO:0030208) dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.3 | 1.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 5.2 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.3 | 0.5 | GO:0014732 | skeletal muscle atrophy(GO:0014732) striated muscle atrophy(GO:0014891) |
0.3 | 3.0 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.3 | 8.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.3 | 0.3 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.3 | 0.3 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.3 | 2.4 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.3 | 0.8 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 1.6 | GO:0090399 | replicative senescence(GO:0090399) |
0.3 | 1.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 0.8 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.3 | 0.5 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.3 | 1.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 0.8 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 1.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 0.8 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 0.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 1.0 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 0.5 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.3 | 1.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.3 | 1.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.3 | 2.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 0.8 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.3 | 1.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 0.3 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.3 | 1.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 0.3 | GO:0051665 | membrane raft localization(GO:0051665) |
0.3 | 0.8 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 2.0 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.2 | 0.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.5 | GO:0060013 | righting reflex(GO:0060013) |
0.2 | 0.7 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 1.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.2 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.2 | 1.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 6.4 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.2 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.2 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.2 | 0.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.2 | 0.5 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.2 | 1.0 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 2.9 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.2 | 0.7 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.9 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 0.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 0.5 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 0.7 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 0.9 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 0.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.9 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.2 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.2 | 1.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 0.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 1.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 2.9 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.2 | 0.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 2.0 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 0.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.2 | 0.2 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 1.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 0.7 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 1.5 | GO:0006266 | DNA ligation(GO:0006266) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 0.2 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.2 | 0.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 2.9 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.2 | 2.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.8 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.8 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 0.4 | GO:0035932 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.2 | 0.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 0.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.2 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 1.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 2.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 0.4 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.2 | 0.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 1.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 0.6 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.2 | 0.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.4 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 3.0 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 0.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.2 | 0.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.9 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.2 | 0.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 1.4 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.2 | 2.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.5 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 1.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 0.9 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 0.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 0.4 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.2 | 0.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.5 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.2 | 0.3 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.2 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.5 | GO:0010637 | regulation of mitochondrial fusion(GO:0010635) negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 1.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.2 | 0.3 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.2 | 0.3 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.2 | 0.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 1.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 1.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 1.6 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.8 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 0.5 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.2 | 0.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.2 | GO:0060004 | reflex(GO:0060004) |
0.2 | 1.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 0.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.2 | 1.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.6 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.4 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.3 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.3 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.6 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.7 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.6 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 1.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.1 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.6 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.7 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.3 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.1 | 0.1 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.1 | 0.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 1.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.3 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.3 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.1 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.7 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 2.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.3 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.4 | GO:1903660 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.8 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 1.2 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 1.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 2.7 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.1 | GO:0032513 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.1 | 2.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 1.9 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.1 | 0.5 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 0.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.1 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.1 | 1.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 3.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.2 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.4 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.7 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 1.3 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 1.9 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.4 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.6 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.3 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.2 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.2 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.1 | 0.8 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.2 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.5 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.2 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.1 | 0.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0086019 | cell-cell signaling involved in cardiac conduction(GO:0086019) |
0.1 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 1.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 1.2 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 2.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.3 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 1.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.1 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.4 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.1 | 0.1 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.4 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.9 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.5 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 0.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.6 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.6 | GO:0001736 | establishment of planar polarity(GO:0001736) |
0.1 | 0.3 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.1 | GO:0002434 | immune complex clearance(GO:0002434) |
0.1 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.2 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.8 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.2 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.3 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.6 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.1 | 0.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 | 0.3 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.1 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.1 | 0.7 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.2 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.2 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.1 | 0.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.1 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.1 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.3 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.1 | 0.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.0 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.0 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.3 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.1 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.0 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.4 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.0 | 0.1 | GO:0009197 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.0 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 1.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 1.8 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.2 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.1 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
0.0 | 0.3 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.0 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.0 | 0.1 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.2 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.0 | 0.4 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.0 | 0.0 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.0 | 0.0 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.0 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.0 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.0 | 0.0 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.0 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.0 | 0.1 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.0 | 0.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.1 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.0 | 0.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.0 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.1 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.0 | 0.1 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.0 | 0.0 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.0 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.0 | 0.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.0 | 0.0 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.0 | 0.0 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.0 | 0.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.0 | 0.2 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.0 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.0 | 0.1 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.0 | 0.6 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.1 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.0 | 0.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.0 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 0.0 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.0 | 0.0 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 14.0 | GO:0005914 | spot adherens junction(GO:0005914) |
3.8 | 11.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.9 | 8.8 | GO:1990812 | growth cone filopodium(GO:1990812) |
2.7 | 31.8 | GO:0043194 | axon initial segment(GO:0043194) |
2.3 | 49.1 | GO:0030057 | desmosome(GO:0030057) |
2.1 | 8.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.8 | 29.5 | GO:0030673 | axolemma(GO:0030673) |
1.8 | 52.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.6 | 4.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.6 | 6.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
1.5 | 9.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.3 | 4.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.3 | 6.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.3 | 2.7 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.3 | 5.1 | GO:0044308 | axonal spine(GO:0044308) |
1.2 | 3.7 | GO:0043511 | inhibin complex(GO:0043511) |
1.2 | 8.3 | GO:0043083 | synaptic cleft(GO:0043083) |
1.2 | 16.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.1 | 4.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.1 | 31.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.1 | 14.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.1 | 5.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.0 | 2.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.0 | 3.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.0 | 23.5 | GO:0032589 | neuron projection membrane(GO:0032589) |
1.0 | 1.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.0 | 9.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.0 | 4.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.9 | 3.8 | GO:1990696 | USH2 complex(GO:1990696) |
0.9 | 14.0 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.9 | 27.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.9 | 2.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.9 | 26.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.9 | 4.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.9 | 7.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.9 | 4.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.8 | 6.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.8 | 0.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.8 | 0.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.8 | 39.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.7 | 2.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.7 | 3.7 | GO:0097433 | dense body(GO:0097433) |
0.7 | 18.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.7 | 2.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.7 | 9.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.6 | 4.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.6 | 0.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.6 | 1.9 | GO:0072534 | perineuronal net(GO:0072534) |
0.6 | 4.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.6 | 4.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.6 | 1.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.6 | 1.7 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.6 | 3.4 | GO:0044292 | dendrite terminus(GO:0044292) |
0.6 | 1.7 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.5 | 1.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.5 | 4.4 | GO:0071437 | invadopodium(GO:0071437) |
0.5 | 2.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.5 | 1.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.5 | 1.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.5 | 5.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.5 | 6.6 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 1.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.5 | 3.3 | GO:0000801 | central element(GO:0000801) |
0.5 | 66.7 | GO:0060076 | excitatory synapse(GO:0060076) |
0.5 | 3.6 | GO:0044298 | cell body membrane(GO:0044298) |
0.4 | 2.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 2.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.4 | 1.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.4 | 2.0 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.4 | 1.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 1.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 6.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 33.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 1.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.4 | 1.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 1.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.4 | 2.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 1.0 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 2.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 1.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 2.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 1.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 19.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 1.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 1.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 4.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 2.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 0.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.3 | 3.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 2.7 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 3.6 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.3 | 2.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 1.2 | GO:0032021 | NELF complex(GO:0032021) |
0.3 | 8.3 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 1.9 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 2.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 1.3 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 1.1 | GO:0097449 | astrocyte projection(GO:0097449) |
0.3 | 3.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 0.5 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 0.7 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 1.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.2 | 0.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 1.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 0.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.4 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 2.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 1.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 25.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 2.0 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 1.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 0.6 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 11.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 1.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 1.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 2.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 10.3 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 1.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 0.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 1.4 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.2 | 0.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 2.2 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.9 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 0.8 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.2 | 1.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 6.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 9.0 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 2.6 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 1.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.5 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 1.7 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 1.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 3.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 1.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 3.3 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 2.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 1.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.4 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 1.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 12.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 2.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.1 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.2 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.0 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.7 | 46.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
6.8 | 20.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
4.0 | 12.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
4.0 | 12.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
3.2 | 9.7 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
2.9 | 11.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.9 | 8.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
2.8 | 14.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.6 | 7.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.4 | 7.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.4 | 11.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
2.3 | 11.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
2.3 | 11.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.2 | 8.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.2 | 4.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.1 | 10.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.0 | 12.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
2.0 | 20.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.9 | 5.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.9 | 5.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.9 | 1.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.8 | 7.3 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
1.8 | 5.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.8 | 5.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.7 | 13.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.7 | 5.0 | GO:0097016 | L27 domain binding(GO:0097016) |
1.6 | 3.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.6 | 6.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.6 | 12.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.5 | 6.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.5 | 7.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.5 | 10.2 | GO:0003680 | AT DNA binding(GO:0003680) |
1.4 | 5.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.4 | 4.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.4 | 4.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.4 | 9.6 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.3 | 17.9 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
1.3 | 5.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.2 | 2.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.2 | 2.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.2 | 3.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.1 | 3.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.1 | 3.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.1 | 1.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.1 | 8.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.1 | 3.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.1 | 19.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
1.0 | 3.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.0 | 4.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.0 | 30.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.0 | 10.9 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
1.0 | 4.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.0 | 2.9 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.9 | 2.7 | GO:0035939 | microsatellite binding(GO:0035939) |
0.9 | 3.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.9 | 22.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.9 | 3.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.9 | 9.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.9 | 2.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.9 | 2.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.9 | 0.9 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.8 | 16.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.8 | 7.5 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.8 | 12.4 | GO:0031402 | sodium ion binding(GO:0031402) |
0.8 | 1.6 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.8 | 4.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.8 | 6.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.8 | 8.5 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 2.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.7 | 3.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.7 | 17.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.7 | 3.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.7 | 11.6 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.7 | 3.6 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.7 | 10.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.7 | 1.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.7 | 2.1 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.7 | 2.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.7 | 10.4 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.7 | 9.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.7 | 2.8 | GO:0070052 | collagen V binding(GO:0070052) |
0.7 | 3.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.7 | 1.4 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.7 | 0.7 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.6 | 3.9 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.6 | 8.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.6 | 4.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.6 | 3.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.6 | 1.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.6 | 9.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.6 | 0.6 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.6 | 1.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.6 | 1.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.6 | 7.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.6 | 4.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.6 | 2.9 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.6 | 4.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.6 | 2.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.6 | 2.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.6 | 0.6 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.5 | 2.7 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.5 | 2.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.5 | 1.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.5 | 2.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.5 | 2.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.5 | 2.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.5 | 2.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.5 | 5.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.5 | 2.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 2.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.5 | 2.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.5 | 23.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.5 | 3.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.5 | 13.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 2.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.5 | 1.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 7.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.5 | 6.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 0.5 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.5 | 0.5 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.5 | 4.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 1.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 2.8 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 1.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.5 | 26.2 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.5 | 1.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.5 | 1.4 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.5 | 1.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 1.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.5 | 1.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.5 | 1.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 10.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 2.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 1.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.4 | 2.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.4 | 17.7 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.4 | 2.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.4 | 0.9 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.4 | 10.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 1.8 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 1.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 1.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 2.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.4 | 2.1 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.4 | 1.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.4 | 1.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.4 | 4.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 1.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 1.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.4 | 1.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 1.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.4 | 2.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 1.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 1.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 11.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 0.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 1.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.4 | 4.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 10.8 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.4 | 3.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.4 | 0.7 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.4 | 2.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 4.3 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 4.3 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.4 | 7.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 5.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 3.1 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.3 | 1.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 0.7 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 1.4 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 5.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 2.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.3 | 1.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 1.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 1.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 2.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 2.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 2.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 3.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 0.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 1.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 0.9 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 3.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 4.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 1.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 1.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 1.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 0.9 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 1.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.3 | 0.8 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 2.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 11.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 3.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 0.3 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.3 | 0.8 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 3.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 3.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.3 | 1.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.3 | 0.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 2.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 4.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 0.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 2.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 0.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 1.7 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 1.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 6.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 8.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 0.7 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 0.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 6.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.6 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 3.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 6.1 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 1.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 1.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.7 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 1.3 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 1.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.9 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 0.6 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 1.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 3.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 6.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 1.9 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.2 | 0.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 1.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 0.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 1.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.2 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.2 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 1.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 4.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 3.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 2.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 0.6 | GO:0033192 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 1.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 1.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 0.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 3.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 2.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 2.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 16.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 2.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 1.9 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.2 | 1.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 2.8 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 0.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.6 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.6 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 1.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 1.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 1.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.4 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.1 | 1.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 1.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.3 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 0.4 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 2.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 3.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 3.0 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 6.9 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 2.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 1.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.0 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.1 | 0.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.9 | GO:0052769 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.1 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 1.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 1.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 1.4 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 1.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.3 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.7 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.1 | GO:0018592 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.9 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 21.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.0 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 1.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.2 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.0 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.1 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.0 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 9.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
2.2 | 2.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.4 | 2.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.8 | 24.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.8 | 2.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.7 | 2.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.7 | 0.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.7 | 10.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.7 | 1.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.6 | 8.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.5 | 6.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.5 | 2.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 10.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.4 | 12.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 13.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 2.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 2.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 9.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 1.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 9.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 7.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 4.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 4.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 0.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 1.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 2.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 35.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 1.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 7.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 46.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
2.5 | 54.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
2.5 | 2.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.7 | 24.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.6 | 23.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.5 | 16.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.5 | 21.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.3 | 18.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.3 | 15.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.2 | 53.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.1 | 11.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.1 | 15.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.1 | 12.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.0 | 3.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.9 | 10.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.7 | 6.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.7 | 13.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.7 | 12.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.7 | 17.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.7 | 7.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.7 | 16.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.6 | 1.9 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.6 | 12.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 4.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.6 | 7.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.6 | 5.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.6 | 2.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.6 | 6.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.5 | 8.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 5.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.5 | 2.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.5 | 17.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.5 | 8.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.5 | 0.5 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.5 | 0.5 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.5 | 0.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.5 | 2.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.5 | 18.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.5 | 1.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.4 | 0.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.4 | 4.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 3.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.4 | 5.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.4 | 3.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.4 | 0.4 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.4 | 4.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 3.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.4 | 3.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.4 | 2.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 3.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 2.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 4.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 2.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.3 | 2.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 0.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 2.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 1.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 2.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 5.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 4.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 3.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 4.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 2.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 0.6 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.2 | 1.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 4.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 1.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 1.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.2 | 0.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 2.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 0.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 2.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 2.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 2.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 4.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 5.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.3 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 0.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 1.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.1 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.1 | 0.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 0.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.0 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 1.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 1.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |